Asset Allocation

As of March 31, 2026.
Type % Net
Cash 0.69%
Stock 69.62%
Bond 6.83%
Convertible 16.06%
Preferred 4.46%
Other 2.35%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 68.13%
Mid 15.74%
Small 16.13%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 81.31%    % Emerging Markets: 0.35%    % Unidentified Markets: 18.34%

Americas 72.87%
72.62%
Canada 2.08%
United States 70.54%
0.25%
Mexico 0.02%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 6.60%
United Kingdom 2.98%
3.62%
Finland 0.00%
France 0.44%
Germany 0.24%
Ireland 1.31%
Italy 0.17%
Netherlands 0.40%
Spain 0.01%
Switzerland 1.03%
0.00%
0.00%
Greater Asia 2.19%
Japan 0.22%
0.00%
1.97%
South Korea 1.18%
Taiwan 0.80%
0.00%
Unidentified Region 18.34%

Bond Credit Quality Exposure

AAA 0.00%
AA 0.11%
A 0.16%
BBB 19.82%
BB 4.30%
B 0.98%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 74.64%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
41.76%
Materials
1.28%
Consumer Discretionary
6.88%
Financials
12.98%
Real Estate
20.63%
Sensitive
28.02%
Communication Services
2.99%
Energy
8.07%
Industrials
8.40%
Information Technology
8.57%
Defensive
26.02%
Consumer Staples
9.09%
Health Care
12.84%
Utilities
4.09%
Not Classified
4.19%
Non Classified Equity
1.97%
Not Classified - Non Equity
2.22%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 4.39%
Corporate 77.29%
Securitized 0.00%
Municipal 0.00%
Other 18.32%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.39%
Less than 1 Year
4.39%
Intermediate
0.18%
1 to 3 Years
0.10%
3 to 5 Years
0.08%
5 to 10 Years
0.00%
Long Term
16.70%
10 to 20 Years
0.00%
20 to 30 Years
7.35%
Over 30 Years
9.35%
Other
78.73%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial